Literature DB >> 3291448

Type b capsular polysaccharide as a virulence factor of Haemophilus influenzae.

E R Moxon1, J S Kroll.   

Abstract

The capsular polysaccharide of Haemophilus influenzae serotype b [(3)-beta-D-ribose-(1-1)-ribitol-5-phosphate] is a major virulence factor and a target for serum antibodies which protect individuals against invasive infections. Studies in an experimental rat model of meningitis, using genetically defined H. influenzae transformants, provide evidence that chromosomal genes within or limited to a region (cap b) containing genes necessary for type b capsule are critical for efficient intravascular survival of H. influenzae. Within cap b there is a duplication of a 17 kb region organized as direct repeats separated by a smaller (1-2 kb) region of non-repeated DNA. Homologous recombination between the direct repeats is rec dependent and results in high-frequency loss of capsule expression and virulence.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3291448     DOI: 10.1016/s0264-410x(88)80011-2

Source DB:  PubMed          Journal:  Vaccine        ISSN: 0264-410X            Impact factor:   3.641


  11 in total

Review 1.  Common themes in microbial pathogenicity.

Authors:  B B Finlay; S Falkow
Journal:  Microbiol Rev       Date:  1989-06

2.  Emergence of non-serotype b encapsulated Haemophilus influenzae as a cause of pediatric meningitis in northwestern Ontario.

Authors:  Pouya Sadeghi-Aval; Raymond Sw Tsang; Frances B Jamieson; Marina Ulanova
Journal:  Can J Infect Dis Med Microbiol       Date:  2013       Impact factor: 2.471

3.  Altered lipopolysaccharide characteristic of the I69 phenotype in Haemophilus influenzae results from mutations in a novel gene, isn.

Authors:  A Preston; D Maskell; A Johnson; E R Moxon
Journal:  J Bacteriol       Date:  1996-01       Impact factor: 3.490

4.  Adhesin genes and serum resistance in Haemophilus influenzae type f isolates.

Authors:  Michael E Watson; Kevin L Nelson; Victoria Nguyen; Carey-Ann D Burnham; Jill E Clarridge; Xuan Qin; Arnold L Smith
Journal:  J Med Microbiol       Date:  2012-12-14       Impact factor: 2.472

Review 5.  Antibiotic resistance in Haemophilus influenzae: mechanisms, clinical importance and consequences for therapy.

Authors:  R de Groot; G Dzoljic-Danilovic; B van Klingeren; W H Goessens; H J Neyens
Journal:  Eur J Pediatr       Date:  1991-06       Impact factor: 3.183

6.  Kingella kingae Surface Polysaccharides Promote Resistance to Human Serum and Virulence in a Juvenile Rat Model.

Authors:  Vanessa L Muñoz; Eric A Porsch; Joseph W St Geme
Journal:  Infect Immun       Date:  2018-05-22       Impact factor: 3.441

7.  Evolutionary Model of Cluster Divergence of the Emergent Marine Pathogen Vibrio vulnificus: From Genotype to Ecotype.

Authors:  Mario López-Pérez; Jane M Jayakumar; Jose M Haro-Moreno; Asier Zaragoza-Solas; Geethika Reddi; Francisco Rodriguez-Valera; Orr H Shapiro; Munirul Alam; Salvador Almagro-Moreno
Journal:  mBio       Date:  2019-02-19       Impact factor: 7.867

8.  Gene content and diversity of the loci encoding biosynthesis of capsular polysaccharides of the 15 serovar reference strains of Haemophilus parasuis.

Authors:  Kate J Howell; Lucy A Weinert; Shi-Lu Luan; Sarah E Peters; Roy R Chaudhuri; David Harris; Oystein Angen; Virginia Aragon; Julian Parkhill; Paul R Langford; Andrew N Rycroft; Brendan W Wren; Alexander W Tucker; Duncan J Maskell
Journal:  J Bacteriol       Date:  2013-07-19       Impact factor: 3.490

9.  The Glaesserella parasuis phosphoglucomutase is partially required for lipooligosaccharide synthesis.

Authors:  Saixiang Feng; Aihua Chen; Xiaobing Wang; Zhichao Pan; Siqi Xu; Huiwen Yu; Bin Zhang; Ming Liao
Journal:  Vet Res       Date:  2020-07-31       Impact factor: 3.683

10.  Non-Typeable Haemophilus influenzae Invade Choroid Plexus Epithelial Cells in a Polar Fashion.

Authors:  Christian Wegele; Carolin Stump-Guthier; Selina Moroniak; Christel Weiss; Manfred Rohde; Hiroshi Ishikawa; Horst Schroten; Christian Schwerk; Michael Karremann; Julia Borkowski
Journal:  Int J Mol Sci       Date:  2020-08-10       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.